Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 2
Submit an article Journal homepage
17
Views
0
CrossRef citations to date
0
Altmetric
Articles

Prevalence of atrial fibrillation in hospitalized patients over 40 years old: ten-year data from the People’s Hospital of Peking University

Yuansheng LiuDept. of Emergency, People’s Hospital of Peking University, Beijing, China.Correspondence[email protected]
, PhD,
Hao LiuDept. of Emergency, People’s Hospital of Peking University, Beijing, China.
,
Lei DongDept. of Cardiology, the Sixth Hospital of Beijing, Beijing, China.
,
Jie ChenDept. of Epidemiology, People’s Hospital of Peking University, Beijing, China.
&
Jihong GuoDept. of Cardiology, People’s Hospital of Peking University, Beijing, China.
, PhD
Pages 221-224 | Received 29 Jan 2010, Published online: 23 May 2017

References

  • Go AS. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol 2005; 14: 56–61.
  • Kannel WB, Benjamin EJ. Current perceptions of the epide-miology of atrial fibrillation. Cardiol OM 2009; 27: 13–24.
  • Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D’Agostino RB Sr, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373: 739–45.
  • Karagiannis A, Mikhailidis DP, Tziomalos K, Sileli M, Savvatianos S, Kakafika A, Gossios T, Krikis N, Moschou I, Xochellis M, Athyros VG. Serum uric acid as an indepen-dent predictor of early death after acute stroke. Circ J2007; 71: 1120–7.
  • Chen LY, Shen WK. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm 2007; 4: S1–6.
  • Pan NH, Tsao HM, Chang NC, Chen YJ, Chen SA. Aging dilates atrium and pulmonary veins: implications for the genesis of atrial fibrillation. Chest 2008; 133: 190–6.
  • Kannel WB, Benjamin EJ. Status of the epidemiology of atrial fibrillation. Med Clin North Am 2008; 92: 17-40, ix.
  • Anyukhovsky EP, Sosunov EA, Chandra P, Rosen TS, Boyden PA, Danilo P Jr, Rosen MR. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. Cardiovasc Res 2005; 66: 353–63.
  • Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhyth-mias on ambulatory Holter electrocardiogram in hyper-trophic cardiomyopathy. J Am Coll Cardiol 2005; 45: 697–704.
  • Theofilogiannakos EK, Anogeianaki A, Tsekoura P, Glouft-sios P, Ilonidis G, Hatzitolios A, Anogianakis G. Arrhyth-mogenesis in patients with stable chronic obstructive pul-monary disease. J Cardiovasc Med (Hagerstown) 2008; 9: 89–93.
  • Cuoco FA, Singh SN. Nonsustained ventricular tachycardia in dilated cardiomyopathy. Curr Cardiol Rep 2005; 7: 368–75.
  • Parthenakis Fl, Patrianakos AP, Skalidis El, Diakakis GF, Zacharis EA, Chlouverakis G, Karalis IK, Vardas PE. Atrial fibrillation is associated with increased neurohumoral activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol 2007; 118: 206–14.
  • Iacoviello M, Forleo C, Guida P, Romito R, Sorgente A, Sorrentino S, Catucci S, Mastropasqua F, Pitzalis M. Ven-tricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2007; 50: 225–31.
  • Mukamal KJ, Tolstrup JS, Friberg J, Gronbaek M, Jensen G. Fibrinogen and albumin levels and risk of atrial fibrilla-tion in men and women (the Copenhagen City Heart Study). Am J Cardiol 2006; 98: 75–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.